ELAVL1 and diabetic cardiomyopathy: Thus, miR-21 and miR-122 may be selectively encapsulated in the EVs via HuR and secreted extracellularly, leading to an increase in their extracellular levels while causing a decrease in their intracellular levels, possibly mediating the pathogenic effect of HuR in diabetic cardiomyopathy.